Adenosine triphosphate-dependent transport of estradiol-17β(β-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells

被引:48
作者
Hang, LY [1 ]
Hoffman, T [1 ]
Vore, M [1 ]
机构
[1] Univ Kentucky, Albert B Chandler Med Ctr, Grad Ctr Toxicol, Coll Med,Dept Pharmacol, Lexington, KY 40536 USA
关键词
D O I
10.1002/hep.510280528
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
MDR1, an ABC transporter that confers multidrug resistance in tumor cells, is constitutively expressed in normal liver canalicular membrane. Human MDR1-expressing multidrug-resistant cells display increased resistance to estradiol-17 beta(beta-D-glucuronide) (E(2)17G). MDR1 substrates/ modulators inhibit adenosine triphosphate (ATP)-dependent transport of E(2)17G in the rat canalicular membrane and protect against E(2)17G-mediated cholestasis in isolated perfused rat liver. The present studies were designed to determine if E(2)17G is a substrate for MDR1 using a baculovirus expression system and if other estrogen glucuronides interact with MDR1. ATP-dependent transport of E(2)17G (10 mu mol/L) was linear for up to 2 minutes and yielded a rate of 45.6 pmol/min/mg protein in membrane vesicles from Sf9 cells infected with MDR1-baculovirus. This transport was saturable (K-m = 62 mu mol/L) and occurred into an osmotically sensitive space. ATP-dependent transport of E(2)17G (10 mu mol/L) was inhibited 63% by 10 mu mol/L daunomycin, but not by 100 mu mol/L S-(2,4-dinitrophenyl)glutathione (GS-DNP) (a substrate for canalicular multispecific organic anion transporter [cMOAT]), Glucuronide conjugates of the estrogen D-ring (100 mu mol/L), estriol-17 beta(beta-D-glucuronide) (E(3)17G) and estriol-16 alpha(beta-D-glucuronide) (E(3)16G), inhibited MDR1-mediated E(2)17G transport by 58% and 35%, respectively. In contrast, noncholestatic glucuronides, estradiol-3-(beta-D-glucuronide) (E(2)3G) or estradiol-3-sulfate-17 beta(beta-D-glucuronide) (E(2)3SO(4)17G), had no effect. E(2)17G neither stimulated MDR1 ATPase activity nor inhibited verapamil-stimulated ATPase activity Infusion of 1.5 mu mol/L doxorubicin or 1 mu mol/L taxol protected against cholestasis induced by E(3)16G and E(3)17G in isolated perfused rat liver. These studies identify E(2)17G, and probably E(3)16G and E(3)17G, as endogenous substrates for MDR1.
引用
收藏
页码:1371 / 1377
页数:7
相关论文
共 24 条
[1]  
COHEN L, 1972, GASTROENTEROLOGY, V62, P1182
[2]  
GOSLAND M, 1993, CANCER RES, V53, P5382
[3]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427
[4]  
Jedlitschky G, 1996, CANCER RES, V56, P988
[5]   ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2 [J].
Jedlitschky, G ;
Leier, I ;
Buchholtz, U ;
HummelEisenbeiss, J ;
Burchell, B ;
Keppler, D .
BIOCHEMICAL JOURNAL, 1997, 327 :305-310
[6]  
Keppler D, 1997, BIOL CHEM, V378, P787
[7]  
Liu Y, 1996, CANCER RES, V56, P4992
[8]   ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP) - Inhibition by cholestatic steroids [J].
Loe, DW ;
Almquist, KC ;
Cole, SPC ;
Deeley, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) :9683-9689
[9]   Molecular aspects of hepatobiliary transport [J].
Muller, M ;
Jansen, PLM .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 272 (06) :G1285-G1303
[10]  
NAITO M, 1988, J BIOL CHEM, V263, P11887